MyProstateScore 2.0 is a personalized, comprehensive, data-driven prostate cancer screening solution designed to predict the presence of clinically significant prostate cancer (Grade Group ≥2 or Gleason score ≥7). The algorithm is specifically optimized for unrivaled accuracy for both previously neg... Read more
Atria Institute
3 followers
Truveta
5 followers
Asklepios BioPharmaceutical
2 followers
Alamar Biosciences, Inc.
2 followers
Biolinq
2 followers
Arkana Laboratories
1 follower
REVOLUTION Medicines
19 followers
Amylyx
2 followers
Sirona Medical
1 follower
Rigel Pharmaceuticals
5 followers
Biocytogen
5 followers
Anterior
1 follower